ESR1 and triple-negative breast carcinoma: Triple negative breast cancer (TNBC) accounts for 9–17% of all breast cancer diagnoses [1–3] and is defined by the absence of estrogen receptor (ER), progesterone receptor (PR) and c-erbB2 (HER2) expression.